glp 1 drugs vs phentermine GLP-1: how the two biggest weight loss medication classes compare Pharmacology: Weight Loss Medications, Mechanisms

E.SlatteryJ

Final proof for the proliferative effects of CJC-1295 on somatotroph cells was derived from immunohistochemistry studies of the pituitaries demonstrating that, in active treatment groups, the glands were increased in size and that the increment was due mainly to somatotroph proliferation

Toxicol Appl Pharmacol 207:354366 Hitchler MJ, Domann FE (2007) An epigenetic perspective on the free radical theory of development

doi: 10.1097/01.psy.0000116249.60477.e9 32 SmelandOMeisingsetTBorgesKSonnewaldU

C., Caffo, B., & Pekar, J

10.1001/jamainternmed.2024.4369 Summary Keywords cardiovascular disease, cardiovascular outcome, glucagon-like peptide-1 receptor agonists, heart failure, obesity Citation Turkistani Y (2025) Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective